Evidence map›Paper›PMID 23449702›Full record

ArticleClinical chemistry2013

Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.

Mateus M Bergamaschi, Erin L Karschner, Robert S Goodwin, Karl B Scheidweiler, Jussi Hirvonen, Regina H C Queiroz, Marilyn A Huestis

Open access · bronzeAbstract read
In one paragraph

Article in Clinical chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Bridging THC Knowledge Gaps for Safer Roads: A Call for Action.Clinical pharmacology and therapeutics · 2025
    Article
  15. Observational
  16. Article
  17. Assessing Cannabis Use in People with Psychosis.Cannabis and cannabinoid research · 2024
    Review
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Mateus M BergamaschiChemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Erin L Karschner
Robert S Goodwin
Karl B Scheidweiler
Jussi Hirvonen
Regina H C Queiroz
Marilyn A Huestis
National Institutes of Health · USNational Institute of Mental Health · USNational Institute on Drug Abuse · USUniversidade de São Paulo · BR

Funding

Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of AbuseZIADA000413 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI SCHEIDWEILER, KARL · 2009 to 2016
$6.0M
Smoked Drugs Of Abuse: Pharmacokinetics/PharmacodynamicsZ01DA000413 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HUESTIS, MARILYN A · 1998 to 2008
$746k
Intramural NIH HHS Z01 DA000413Intramural NIH HHS ZIA DA000413
6 · The paper itself

Abstract

backgroundCannabis is the illicit drug most frequently reported with impaired driving and motor vehicle accidents. Some "per se" laws make it illegal to drive with any amount of drug in the body, while others establish blood, saliva, or urine concentrations above which it is illegal to drive. The persistence of Δ(9)-tetrahydrocannabinol (THC) in chronic daily cannabis smokers' blood is unknown.

methodsThirty male chronic daily cannabis smokers resided on a secure research unit for up to 33 days, with daily blood collection. Samples were processed in an ice bath during sample preparation to minimize cannabinoid adsorption onto precipitant material. We quantified THC by 2-dimensional GC-MS.

resultsOf the 30 participants, 27 were THC-positive on admission, with a median (range) concentration of 1.4 μg/L (0.3-6.3). THC decreased gradually; only 1 of 11 participants was negative at 26 days, 2 of 5 remained THC-positive (0.3 μg/L) for 30 days, and 5.0% of participants had THC ≥ 1.0 μg/L for 12 days. Median 11-hydroxy-THC concentrations were 1.1 μg/L on admission, with no results ≥ 1.0 μg/L 24 h later. 11-Nor-9-carboxy-THC (THCCOOH) detection rates were 96.7% on admission, decreasing slowly to 95.7% and 85.7% on days 8 and 22, respectively; 4 of 5 participants remained THCCOOH positive (0.6-2.7 μg/L) after 30 days, and 1 remained positive on discharge at 33 days.

conclusionsCannabinoids can be detected in blood of chronic daily cannabis smokers during a month of sustained abstinence. This is consistent with the time course of persisting neurocognitive impairment reported in recent studies.

Indexed as

AdultAutomobile DrivingDronabinolHumansMaleMarijuana AbuseMiddle AgedSubstance Abuse Detection11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acidDronabinol

Identifiers

PMID23449702
PMCPMC3717350
OpenAlexW2027835625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.